Evaluation of the effectiveness of hyaluronic acid for the treatment of seborrheic dermatitis of the face

G. Hakobyan, I. Komissarova, Z. Evsyukova, Elena Ribakova, Armen Haruthyunyan
{"title":"Evaluation of the effectiveness of hyaluronic acid for the treatment of seborrheic dermatitis of the face","authors":"G. Hakobyan, I. Komissarova, Z. Evsyukova, Elena Ribakova, Armen Haruthyunyan","doi":"10.31579/2692-9406/031","DOIUrl":null,"url":null,"abstract":"Objectives: The aim of the study was to assess the efficacy of 5% hyaluronic acid crem for the treatment of seborrheic dermatitis of the face. Materials and methods: A total of 49 patients (28 men and 21 women, age from 31 to 64 years) with seborrheic dermatitis of the face were selected for the study. A single-site, prospective observational study of 5% hyaluronic acid cream for the treatment of facial seborrheic dermatitis was conducted from 2016 to 2020. All patients underwent a thorough clinical examination according to the generally accepted scheme. Treatment planning includes a thorough history and physical examination, preoperative laboratory examination. At each visit, degrees of scale, erythema, and pruritus were evaluated. To assess the effectiveness of patients were given a questionnaire to fill out the questions. The questionnaire evaluated the 5% hyaluronic acid crem effectiveness of the treatment. Outcome was the evolution of the Investigator Global Assessment (IGA) scale, assessing erythema, scale / scaling, seborrhea and pruritus, all measured on a five-point scale, from 0: no signs / symptoms to 4: very severe sign / symptom. Subjects were assessed at baseline after 4 and 8 weeks. Results: Baseline IGA scores (mean ± SD) were 9 ± 3 (range: 5-13). The use of the EDS significantly reduced the IGA score by 67% at 4 week and by 83% at 8 week. The condition improved from baseline in 92.3% of subjects. Conclusion: 5% hyaluronic acid crem has been effective in reducing erythema, scales, seborrhea, and itching. No local side effects were reported.","PeriodicalId":72392,"journal":{"name":"Biomedical research and clinical reviews","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical research and clinical reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31579/2692-9406/031","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Objectives: The aim of the study was to assess the efficacy of 5% hyaluronic acid crem for the treatment of seborrheic dermatitis of the face. Materials and methods: A total of 49 patients (28 men and 21 women, age from 31 to 64 years) with seborrheic dermatitis of the face were selected for the study. A single-site, prospective observational study of 5% hyaluronic acid cream for the treatment of facial seborrheic dermatitis was conducted from 2016 to 2020. All patients underwent a thorough clinical examination according to the generally accepted scheme. Treatment planning includes a thorough history and physical examination, preoperative laboratory examination. At each visit, degrees of scale, erythema, and pruritus were evaluated. To assess the effectiveness of patients were given a questionnaire to fill out the questions. The questionnaire evaluated the 5% hyaluronic acid crem effectiveness of the treatment. Outcome was the evolution of the Investigator Global Assessment (IGA) scale, assessing erythema, scale / scaling, seborrhea and pruritus, all measured on a five-point scale, from 0: no signs / symptoms to 4: very severe sign / symptom. Subjects were assessed at baseline after 4 and 8 weeks. Results: Baseline IGA scores (mean ± SD) were 9 ± 3 (range: 5-13). The use of the EDS significantly reduced the IGA score by 67% at 4 week and by 83% at 8 week. The condition improved from baseline in 92.3% of subjects. Conclusion: 5% hyaluronic acid crem has been effective in reducing erythema, scales, seborrhea, and itching. No local side effects were reported.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
透明质酸治疗面部脂溢性皮炎的疗效评价
目的:评价5%透明质酸乳膏治疗面部脂溢性皮炎的疗效。材料和方法:选择49例面部脂溢性皮炎患者(28男21女,年龄31~64岁)进行研究。2016年至2020年,对5%透明质酸乳膏治疗面部脂溢性皮炎进行了一项单点前瞻性观察研究。所有患者都按照公认的方案进行了彻底的临床检查。治疗计划包括彻底的病史和身体检查,术前实验室检查。每次就诊时,评估鳞屑、红斑和瘙痒的程度。为了评估患者的有效性,给他们一份问卷来填写问题。问卷评估了5%透明质酸crem治疗的有效性。结果是研究者全球评估(IGA)量表的演变,评估红斑、鳞屑/鳞屑、脂溢和瘙痒,所有这些都是在五点量表上测量的,从0:无体征/症状到4:非常严重的体征/症状。受试者在4周和8周后进行基线评估。结果:基线IGA评分(平均值±SD)为9±3(范围:5-13)。EDS的使用使IGA评分在第4周显著降低67%,在第8周显著降低83%。92.3%的受试者病情较基线有所改善。结论:5%透明质酸乳膏对红斑、鳞屑、脂溢、瘙痒有明显的治疗作用。未报告局部副作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Impact of G6pd Deficiency on Sickle Cell Disease in Children in Kinshasa Hospitals: A Case-Control Study Why only a man turned out to be the owner of mind? Morbus Gaucher a diagnostic challenge Right Bundle Branch Block as a Form of Presentation of Acute Myocardial Infarction How and Why Macrophages are Connected with the Parkinson’s Disease: A Short Review to Develop a Therapeutic Strategy for PD
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1